Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-01-25 @ 6:58 PM
Study NCT ID:
NCT00787761
Status:
COMPLETED
Last Update Posted:
2012-10-01
First Post:
2008-11-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
Sponsor:
Northside Hospital, Inc.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000618483
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |